Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
L-NAME Hydrochloride: Reading NO Beyond the Signal
2026-09-24
L-NAME Hydrochloride is a competitive NOS inhibitor for probing how nitric oxide contributes to vascular and inflammatory responses. This article explains how to distinguish direct enzyme inhibition from upstream inflammatory regulation, using recent chlorogenic acid–metal findings to sharpen assay interpretation.
-
Dacarbazine Workflows for DNA-Damage Assays
2026-09-24
Build reproducible Dacarbazine experiments around fresh preparation, dose–response testing, and orthogonal readouts—not viability alone. This guide also explains why metabolism and supportive-care questions require separate experimental designs, with practical starting parameters for melanoma, lymphoma, and sarcoma models.
-
Dacarbazine Workflows for Cancer DNA Damage Research
2026-09-24
Build more interpretable Dacarbazine experiments by controlling fresh preparation, exposure, solvent, and assay timing. This practical guide distinguishes in-vitro cytotoxicity from clinical treatment and supportive-care outcomes across melanoma, lymphoma, and sarcoma research.
-
SERCA2 Dysfunction, FABP4, and Atherosclerosis
2026-09-23
The reference study identifies the calcineurin/FoxO1/FABP4 pathway as a mechanistic link between SERCA2 dysfunction, altered fatty acid handling, macrophage foam cell formation, and atherosclerosis. Its combination of a SERCA2 C674S knock-in model, metabolomics, macrophage assays, pharmacological inhibition, and partial FABP4 deficiency supports FABP4 as an intervention point rather than a passive disease marker.
-
Beclin1, Ferroptosis, and DOX Liver Injury
2026-09-22
The reference study identifies Beclin1 as a potentially harmful regulator of doxorubicin-induced liver injury by linking excessive autophagy with ferroptotic lipid damage. Its results position DHODH as a downstream protective component and show how combined assessment of oxidative stress, iron handling, lipid peroxidation, and pathway markers can clarify mechanism.
-
MCL-1 Inhibition: From Apoptosis to Translation
2026-09-22
A mechanistic and translational framework for using MCL-1 inhibitor A-1210477 to interrogate cancer cell survival regulation, validate mitochondrial apoptosis, and distinguish target dependence from nonspecific cytotoxicity.
-
GKT137831 at the Redox–Ferroptosis Interface
2026-09-21
A translational perspective on how dual Nox1/Nox4 inhibition can clarify oxidative stress biology, vascular remodeling, fibrosis, and emerging ferroptosis research without overstating the current evidence.
-
ARID1A-Dependent Resistance in Melanoma
2026-09-21
This reference study uses integrative multi-omics and network analysis to define how ARID1A loss rewires early signaling responses to BRAF/MAPK inhibition in melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a framework for studying adaptive drug tolerance and immune-related changes beyond single-pathway measurements.
-
TMEM16F Lipid Scrambling in Ferroptosis and Immunity
2026-09-20
Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as an execution-stage suppressor of ferroptosis. The study links failed membrane repair to lytic death, danger-signal release, slower tumor growth, and enhanced response to PD-1 blockade, providing a mechanistic bridge between membrane biophysics and tumor immunology.
-
Masitinib (AB1010) KIT/PDGFR Workflow Guide
2026-09-19
Masitinib (AB1010) is a DMSO-compatible phenylaminothiazole-type tyrosine kinase inhibitor for focused studies of KIT, PDGFRα, PDGFRβ, mast cell behavior, and KIT-mutant tumor models. It is appropriate for defined in vitro or preclinical workflows, but should not be selected for aqueous or ethanol-based assays, broad-spectrum kinase suppression, or clinical use without separate regulatory and safety evaluation.
-
Dietary Arachidonic Acid and Humoral Immunity
2026-09-19
The reference study shows that dietary Arachidonic Acid can accelerate and strengthen rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its central mechanistic contribution is linking lymph-node arachidonate metabolism, prostaglandin I2 signaling, and germinal-center B-cell activity, while also identifying important questions about dose, safety, and transferability.
-
VEGFC–Macrophage Signaling in NASH Fibrosis
2026-09-18
A 2026 Phytomedicine study identifies a hepatocyte-derived VEGFC–VEGFR-3–macrophage axis that promotes inflammation and fibrosis in high-fat diet-induced NASH. Pharmacological inhibition with SAR131675, hepatocyte-specific Vegfc deletion, and in vitro coculture experiments together indicate that this pathway regulates macrophage recruitment and Ly6Chigh-to-Ly6Clow phenotypic transition.
-
Muscle BDNF and Early Neuromuscular Synapse Assembly
2026-09-17
Zhang and colleagues show that muscle-derived BDNF is trafficked to podosome-like structures, released in an activity- and calcium-dependent manner, and proteolytically processed to regulate the earliest organization of acetylcholine receptor clusters. By combining live imaging, targeted perturbations, nerve or agrin stimulation, and muscle-specific knockout mice, the study connects localized neurotrophin signaling with neuromuscular junction assembly in vitro and in vivo.
-
PtrbZIP12 Links Phosphorylation to Poplar Drought Tolerance
2026-09-17
The reference study identifies PtrbZIP12 as a positive regulator of drought resistance in Populus trichocarpa and shows that it directly activates PtrDHN and PtrPOD. By connecting transcriptional regulation with phosphorylation-dependent control, the work provides a mechanistic framework for studying stress-responsive signal transduction in trees.
-
S. eriocheiris Entry into Drosophila S2 Cells
2026-09-17
Wei and colleagues established a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris enters insect cells through clathrin-dependent endocytosis and macropinocytosis. Their inhibitor, cytoskeletal, and infection assays connect bacterial internalization with subsequent intracellular proliferation, vacuolization, and host-cell injury, providing a useful framework for mechanistic endocytosis research.